Terumo バランスシートの健全性

財務の健全性基準チェック /66

Terumoの総株主資本は¥1,313.5B 、総負債は¥174.8Bで、負債比率は13.3%となります。総資産と総負債はそれぞれ¥1,752.3Bと¥438.8Bです。 Terumoの EBIT は¥161.8Bで、利息カバレッジ比率88.8です。現金および短期投資は¥194.9Bです。

主要情報

13.3%

負債資本比率

JP¥174.80b

負債

インタレスト・カバレッジ・レシオ	88.8x
現金	JP¥194.92b
エクイティ	JP¥1.31t
負債合計	JP¥438.75b
総資産	JP¥1.75t

財務の健全性に関する最新情報

更新なし

Recent updates

財務状況分析

短期負債: 4543 Nの短期資産 ( ¥679.2B ) が短期負債 ( ¥231.0B ) を超えています。

長期負債: 4543 Nの短期資産 ( ¥679.2B ) が長期負債 ( ¥207.7B ) を上回っています。

デット・ツー・エクイティの歴史と分析

負債レベル: 4543 N総負債よりも多くの現金を保有しています。

負債の削減: 4543 Nの負債対資本比率は、過去 5 年間で29.5%から13.3%に減少しました。

債務返済能力: 4543 Nの負債は営業キャッシュフローによって十分にカバーされています ( 110.8% )。

インタレストカバレッジ: 4543 Nの負債に対する利息支払いは EBIT ( 88.8 x coverage) によって十分にカバーされています。

Terumo バランスシートの健全性

財務の健全性 基準チェック /66

主要情報

財務の健全性に関する最新情報

Recent updates

Second quarter 2025 earnings released: EPS: JP¥19.74 (vs JP¥18.49 in 2Q 2024)

Less than half of directors are independent

Terumo Corporation to Report Q2, 2025 Results on Nov 07, 2024

Terumo Corporation (TSE:4543) announces an Equity Buyback for 15,000,000 shares, representing 1.01% for ¥30,000 million.

Terumo Corporation to Report Q1, 2025 Results on Aug 08, 2024

Terumo Cardiovascular Announces 510(K) Clearance for the CDI Oneview™? Monitoring System

Full year 2024 earnings released: EPS: JP¥71.50 (vs JP¥59.50 in FY 2023)

Less than half of directors are independent

Less than half of directors are independent

Terumo Corporation to Report Fiscal Year 2024 Results on May 14, 2024

Terumo Corporation Revises Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024

Terumo Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024

Terumo Corporation, Annual General Meeting, Jun 26, 2024

Terumo Corporation to Report Q3, 2024 Results on Feb 07, 2024

Terumo Corporation to Report Q2, 2024 Results on Nov 14, 2023

Terumo Corporation (TSE:4543) announces an Equity Buyback for 5,000,000 shares, representing 0.67% for ¥20,000 million.

Less than half of directors are independent

Terumo Corporation to Report Q1, 2024 Results on Aug 09, 2023

Terumo Corporation Announces Fiscal Year-End Dividend for the Fiscal Year Ended March 31, 2023, Payable on June 28, 2023; Provides Second Quarter-End Dividend Guidance for the Fiscal Year Ending March 31, 2024 and Provides Year-End Dividend Guidance for the Fiscal Year Ending March 31, 2024

Terumo Corporation, Annual General Meeting, Jun 27, 2023

Less than half of directors are independent

Less than half of directors are independent

Third quarter 2023 earnings released: EPS: JP¥39.97 (vs JP¥28.70 in 3Q 2022)

Terumo Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2023

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Terumo Corporation Announces Dividend for the Second Quarter End of Fiscal Year 2023, Commences Dividend Payments on December 5, 2022; Provides Dividend Guidance for the Fiscal Year Ending March 31, 2023

Terumo Corporation to Report Q3, 2023 Results on Nov 10, 2023

Less than half of directors are independent

Terumo Corporation to Report Q2, 2023 Results on Nov 10, 2022

Mitsui DM Sugar Holdings Co.,Ltd. (TSE:2109) agreed to acquire Enteral formula business of Terumo Corporation from Terumo Corporation (TSE:4543).

NUTRI Co.,Ltd. entered into an agreement to acquire Nutritional food and related product assets of Terumo Corporation.

First quarter 2023 earnings released: EPS: JP¥29.61 (vs JP¥36.90 in 1Q 2022)

Terumo Corporation Provides Dividend Guidance for the Second Quarter of Year Ending March 31, 2023

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Terumo Announces Change in Indication for Dexcom G6 CGM System in Japan

Terumo Corporation (TSE:4543) announces an Equity Buyback for 15,000,000 shares, representing 1.98% for ¥50,000 million.

Less than half of directors are independent

Terumo Corporation to Report Fiscal Year 2022 Results on May 12, 2022

Upcoming dividend of JP¥16.00 per share

Investor sentiment deteriorated over the past week

Less than half of directors are independent

Terumo Corporation, Annual General Meeting, Jun 22, 2022

Terumo Corporation Revises Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2022

Investor sentiment deteriorated over the past week

Less than half of directors are independent

Second quarter 2022 earnings released: EPS JP¥29.22 (vs JP¥23.63 in 2Q 2021)

Less than half of directors are independent

Less than half of directors are independent

財務状況分析

デット・ツー・エクイティの歴史と分析

貸借対照表

健全な企業の発掘

財務の健全性基準チェック /66